source
- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorderSTAT · 23d ago↗ source
- Ebola outbreak exposes a fractured outbreak response systemThe costly threat to employer-based health care, Gen Z doctors, and more health newsSTAT · 23d ago↗ source
- Vera Therapeutics wins FDA nod for closely watched kidney disease drugThe clearance marks another step forward in treatment for IgA nephropathy and sets up a commercial battle with Otsuka, which brought a similar medication to market last year.BioPharma Dive · 23d ago↗ source